|
EP1542997B1
(de)
|
2002-07-24 |
2012-02-29 |
Dermira (Canada), Inc. |
Pyrazolylbenzothiazolderivate und deren verwendung als therapeutische mittel
|
|
WO2004084813A2
(en)
*
|
2003-03-21 |
2004-10-07 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
TW200523262A
(en)
*
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
|
JP4692281B2
(ja)
*
|
2003-08-05 |
2011-06-01 |
味の素株式会社 |
新規アゾール化合物
|
|
US20070004771A1
(en)
*
|
2003-10-06 |
2007-01-04 |
Glaxo Group Limited |
Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors
|
|
US7547779B2
(en)
|
2003-10-06 |
2009-06-16 |
Glaxo Group Limited |
Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
|
|
WO2005037198A2
(en)
*
|
2003-10-06 |
2005-04-28 |
Glaxo Group Limited |
Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
|
|
TW200538453A
(en)
*
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
|
KR20070057965A
(ko)
|
2004-09-21 |
2007-06-07 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
ES2365858T3
(es)
*
|
2004-10-13 |
2011-10-11 |
Merck Patent Gmbh |
Derivados de fenilurea como sustancia inhibidora de tirosina-quinasas para el tratamiento de enfermedades tumorales.
|
|
AU2005309566A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Bicyclic inhibitors or Rho kinase
|
|
EP1848696A1
(de)
|
2005-01-21 |
2007-10-31 |
Schering Corporation |
Als histamin-h3-antagonisten geeignete imidazol- und benzimidazolderivate
|
|
CR9465A
(es)
*
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
AR053364A1
(es)
*
|
2005-04-20 |
2007-05-02 |
Smithkline Beecham |
Compuesto de 1h-imidazo 84,5-c) piridin -2- ilo, composicion farmaceutica que lo comprende, proceso para prepararla y su uso para preparar un medicamento para tratamiento de cancer o artritis
|
|
GB0512844D0
(en)
*
|
2005-06-23 |
2005-08-03 |
Novartis Ag |
Organic compounds
|
|
US20090215857A1
(en)
*
|
2005-09-13 |
2009-08-27 |
Pfizer Products Inc. |
Therapeutic Pyrrolidines
|
|
US7625890B2
(en)
|
2005-11-10 |
2009-12-01 |
Smithkline Beecham Corp. |
Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
|
|
US8022075B2
(en)
|
2005-11-30 |
2011-09-20 |
Fujifilm Ri Pharma Co., Ltd. |
Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
|
|
MX2008008328A
(es)
*
|
2005-12-22 |
2008-09-15 |
Alcon Res Ltd |
(indazol-5-il)-pirazinas y (1,3-dihidro-indol-2-ona)-pirazinas para tratar enfermedades y condiciones mediadas con rho cinasa.
|
|
US8227603B2
(en)
*
|
2006-08-01 |
2012-07-24 |
Cytokinetics, Inc. |
Modulating skeletal muscle
|
|
BRPI0714725B1
(pt)
*
|
2006-08-02 |
2021-05-25 |
Cytokinetics, Inc |
Entidade química, composição farmaceuticamente aceitável, e, uso de uma entidade química
|
|
US8299248B2
(en)
*
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
US7851484B2
(en)
|
2007-03-30 |
2010-12-14 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP2215085B1
(de)
|
2007-10-25 |
2011-09-07 |
AstraZeneca AB |
Für die behandlung von zellproliferativen erkrankungen geeignete pyridin- und pyrazinderivate
|
|
CA2713864A1
(en)
*
|
2008-02-04 |
2009-08-13 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions and methods
|
|
WO2009138229A1
(en)
*
|
2008-05-16 |
2009-11-19 |
Cellzome Ag |
Methods for the identification of parp interacting molecules and for purification of parp proteins
|
|
KR101712576B1
(ko)
|
2008-11-10 |
2017-03-06 |
버텍스 파마슈티칼스 인코포레이티드 |
Atr 키나제의 억제제로서 유용한 화합물
|
|
PL3354650T3
(pl)
|
2008-12-19 |
2022-06-13 |
Vertex Pharmaceuticals Incorporated |
Związki przydatne jako inhibitory kinazy atr
|
|
US8592425B2
(en)
|
2009-01-16 |
2013-11-26 |
Merck Sharp & Dohme Corp. |
Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors
|
|
NZ594064A
(en)
*
|
2009-01-30 |
2012-08-31 |
Glaxosmithkline Llc |
Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
|
|
EP2398897B1
(de)
|
2009-02-20 |
2017-06-28 |
Cellular Dynamics International, Inc. |
Verfahren und zusammensetzungen zur differenzierung von stammzellen
|
|
CA2753679C
(en)
|
2009-02-27 |
2021-03-02 |
Cellular Dynamics International, Inc. |
Differentiation of pluripotent cells
|
|
WO2011034741A1
(en)
*
|
2009-09-15 |
2011-03-24 |
Merck Sharp & Dohme Corp. |
Imidazopyridin-2-one derivatives
|
|
CA2785536C
(en)
*
|
2009-12-30 |
2018-02-27 |
Arqule, Inc. |
Substituted imidazopyridinyl-aminopyridine compounds
|
|
US8962631B2
(en)
|
2010-05-12 |
2015-02-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
JP2013526540A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
|
JP5836367B2
(ja)
|
2010-05-12 |
2015-12-24 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Atrキナーゼ阻害剤として有用な化合物
|
|
WO2011143423A2
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US9096584B2
(en)
|
2010-05-12 |
2015-08-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
JP2013526538A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
|
JP2013529643A
(ja)
|
2010-06-23 |
2013-07-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用なピロロピラジン誘導体
|
|
EP2638149B1
(de)
|
2010-11-12 |
2019-05-15 |
Georgetown University |
Immortalisierung von epithelzellen und verwendungsverfahren dafür
|
|
CA2832100A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
|
JP2014522818A
(ja)
|
2011-06-22 |
2014-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
|
WO2012178125A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2012177852A1
(en)
|
2011-06-24 |
2012-12-27 |
Arqule, Inc |
Substituted imidazopyridinyl compounds
|
|
DK2723741T3
(en)
|
2011-06-24 |
2016-06-06 |
Arqule Inc |
SUBSTITUTED imidazopyridinyl-aminopyridine compounds
|
|
CN102295594B
(zh)
*
|
2011-07-12 |
2016-01-20 |
上海医药工业研究院 |
4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
|
|
CN109316480A
(zh)
|
2011-07-13 |
2019-02-12 |
赛特凯恩蒂克公司 |
组合als疗法
|
|
AU2012315384B2
(en)
|
2011-09-30 |
2017-08-10 |
Vertex Pharmaceuticals Incorporated |
Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors
|
|
US8853217B2
(en)
|
2011-09-30 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
RU2018147217A
(ru)
|
2011-09-30 |
2019-01-18 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
|
|
US8765751B2
(en)
|
2011-09-30 |
2014-07-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
IN2014KN00943A
(de)
|
2011-09-30 |
2015-08-21 |
Vertex Pharma |
|
|
WO2013071090A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
EP2776429A1
(de)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Als atr-kinaseinhibitoren nützliche verbindungen
|
|
US8841450B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
US8841449B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
EP2776421A1
(de)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Als atr-kinasehemmer nützliche verbindungen
|
|
CN104582795B
(zh)
|
2012-04-05 |
2018-04-20 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
|
WO2013163171A1
(en)
|
2012-04-24 |
2013-10-31 |
Kaufman Dan S |
Method for developing natural killer cells from stem cells
|
|
CA2882950A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
|
EP2900223B1
(de)
*
|
2012-09-28 |
2017-10-25 |
Merck Sharp & Dohme Corp. |
Neuartige verbindungen als erk-hemmer
|
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
|
US8912198B2
(en)
|
2012-10-16 |
2014-12-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
LT3418281T
(lt)
|
2012-12-07 |
2021-01-11 |
Vertex Pharmaceuticals Inc. |
Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui
|
|
GB201304526D0
(en)
*
|
2013-03-13 |
2013-04-24 |
Proximagen Ltd |
New compounds
|
|
JP2016520291A
(ja)
|
2013-03-14 |
2016-07-14 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
invitroでの内側神経節隆起前駆細胞の作製
|
|
PT2970205T
(pt)
|
2013-03-14 |
2019-08-26 |
Tolero Pharmaceuticals Inc |
Inibidores da jak2 e da alk2 e métodos para a sua utilização
|
|
WO2014143240A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
|
AU2014267360B2
(en)
|
2013-05-14 |
2018-07-05 |
Active Biotech Ab |
N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
|
|
US9629851B2
(en)
|
2013-09-20 |
2017-04-25 |
Stitching Het Nederlands Kanker Institut—Antoni Van Leeuwenhoek Ziekenhuis |
ROCK in combination with MAPK pathway
|
|
HUE046727T2
(hu)
|
2013-12-06 |
2020-03-30 |
Vertex Pharma |
Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
|
|
EP3134407B1
(de)
*
|
2014-04-22 |
2019-07-10 |
ArQule, Inc. |
Salze und polymorphe einer substituierten imidazopyridinyl-aminopyridin-verbindung
|
|
ES2777608T3
(es)
|
2014-06-05 |
2020-08-05 |
Vertex Pharma |
Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
|
|
US11179394B2
(en)
|
2014-06-17 |
2021-11-23 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of Chk1 and ATR inhibitors
|
|
US20170233698A1
(en)
|
2014-06-27 |
2017-08-17 |
The Regents Of The University Of California |
Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
|
|
GB2548740A
(en)
|
2014-11-25 |
2017-09-27 |
Harvard College |
Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
|
|
US10100285B2
(en)
|
2015-04-03 |
2018-10-16 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
CN107636149A
(zh)
|
2015-04-03 |
2018-01-26 |
普罗帕格尼克斯公司 |
上皮细胞的离体增殖
|
|
JP6869231B2
(ja)
|
2015-09-11 |
2021-05-12 |
プロパジェニクス インコーポレイテッド |
ex vivoでの上皮細胞の増殖
|
|
US11464774B2
(en)
|
2015-09-30 |
2022-10-11 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
WO2017066705A1
(en)
*
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
|
WO2019126567A1
(en)
*
|
2017-12-22 |
2019-06-27 |
Southern Research Institute |
Substituted heterocyclic-pyridinones as hiv-1 nef-hck inhibitors
|
|
KR20210038906A
(ko)
|
2018-07-26 |
2021-04-08 |
스미토모 다이니폰 파마 온콜로지, 인크. |
비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
|
|
WO2020041065A1
(en)
|
2018-08-20 |
2020-02-27 |
Propagenix Inc. |
Epithelial cell spheroids
|
|
CA3110661A1
(en)
|
2018-08-29 |
2020-03-05 |
University Of Massachusetts |
Inhibition of protein kinases to treat friedreich ataxia
|
|
LT3860998T
(lt)
|
2018-10-05 |
2024-06-25 |
Annapurna Bio Inc. |
Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu
|
|
UY38427A
(es)
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
|
CN111732584B
(zh)
*
|
2019-03-25 |
2024-02-27 |
复旦大学 |
二芳基取代稠杂环类化合物及其制备方法和在制药中的用途
|
|
US20230348852A1
(en)
|
2020-04-27 |
2023-11-02 |
Novartis Ag |
Methods and compositions for ocular cell therapy
|
|
KR20240099268A
(ko)
|
2021-10-18 |
2024-06-28 |
에비아 라이프 사이언시스 인코포레이션 |
간 섬유증 치료를 한 조성 및 사용 방법
|
|
JP2024539220A
(ja)
|
2021-10-22 |
2024-10-28 |
エヴィア ライフ サイエンシズ インコーポレイテッド |
細胞外小胞を作製するための方法、組成物、およびその使用方法
|
|
WO2024083237A1
(en)
*
|
2022-10-20 |
2024-04-25 |
Impact Therapeutics (Shanghai) , Inc |
Substituted heteroaryl bicyclic compounds as usp1 inhibitors and the use thereof
|
|
CN122535608A
(zh)
*
|
2024-01-17 |
2026-08-07 |
株式会社Lg化学 |
用作cbp/p300抑制剂的新型化合物以及包含其作为活性成分的用于预防或治疗癌症、炎性障碍或自身免疫性疾病的药物组合物
|
|
CN119235877B
(zh)
*
|
2024-11-08 |
2025-11-11 |
中山大学 |
一种钌(iii)酸盐的组合物及其应用
|